Browsing: novartis

FDA and EMA outline principles for AI use in drug development

Technology

MENA Newswire, SAN FRANCISCO: Global drugmakers are increasingly using artificial intelligence to compress the most time-consuming parts of clinical development, applying the technology to tasks such as selecting trial sites, screening participants, monitoring data flows and assembling regulatory documents. Executives